Abstract
BackgroundThere is a pressing need to identify novel therapeutic approaches and noninvasive biomarkers in lupus nephritis (LN).ObjectivesIn this study, we quantified serum soluble mediators in the large Accelerating Medicines Partnership...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
